Kenvue Inc.NYSE: KVUE

Kenvue to Announce Third Quarter 2026 Results on October 30, 2026

· Issued by Kenvue Inc. via Business Wire

Summary by 6ix AI

Kenvue Inc., a consumer health company whose brands include Tylenol, Listerine and Neutrogena, will release its third quarter 2026 financial results before the market opens on October 30, 2026.

Key details

  • Kenvue will not hold a quarterly conference call to review the results, citing its pending transaction with Kimberly-Clark.
  • The results press release will be posted on the company's investor website.

6ix AI wrote this summary from the release below and checked it against the release.

SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) will announce its third quarter 2026 financial results before the market opens on October 30, 2026. Due to the pending transaction with Kimberly-Clark, Kenvue will not be hosting a quarterly conference call to review its financial results.

The press release will be available on the company’s website at investors.kenvue.com.

About Kenvue
Kenvue Inc. is the world’s largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson’s®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we realize the extraordinary power of everyday care. Our teams work every day to put that power in consumers’ hands and earn a place in their hearts and homes. Learn more at www.kenvue.com.

View original source (Business Wire)Kenvue Inc. on 6ix

Story so far

Earlier from Kenvue

All Kenvue news releases